It is worth noting that compared with normal tissues, TROP2, ERBB3, and MUC1 are significantly upregulated in cervical cancer, ovarian cancer, and endometrial cancer, while MSLN and TM4SF1 are significantly upregulated in cervical cancer and ovarian cancer; the expression of NaPi2b, B7-H4, and CD74 is significantly upregulated in ovarian cancer and endometrial cancer. This evidence concerns the gene SLC34A2 and cervical cancer.